Edwards Martin
Insider CIK 1640073 · KALV Director · RETA Director · VRNA Director · MORF Director · INZY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 64,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 200,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 240,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer deriv | 2025-10-07 | 2025-10-08 | 96,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 72,000 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 72,000 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | D To issuer | 2025-10-07 | 2025-10-08 | 157,992 | — | $0 | 0 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise deriv | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 72,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2025-08-01 | 2025-08-05 | 10,808 | $13.14 | $142.0K | 157,992 | SEC↗ |
| VRNA Verona Pharma plc | M Exercise | 2025-08-01 | 2025-08-05 | 24,000 | — | $0 | 168,800 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2025-04-25 | 2025-04-29 | 96,000 | — | $0 | 96,000 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-21 | 12,535 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-21 | 9,996 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-21 | 24,000 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-21 | 17,550 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer deriv | 2024-08-16 | 2024-08-21 | 23,168 | — | $0 | 0 | SEC↗ |
| MORF Morphic Holding, Inc. | D To issuer | 2024-08-16 | 2024-08-21 | 2,376 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 28,000 | — | $0 | 28,000 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2024-06-04 | 2024-06-05 | 23,168 | — | $0 | 23,168 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2024-04-29 | 2024-04-30 | 240,000 | — | $0 | 240,000 | SEC↗ |
| VRNA Verona Pharma plc | P Buy | 2023-11-20 | 2023-11-22 | 33,736 | $1.84 | $62.1K | 144,800 | SEC↗ |
| MORF Morphic Holding, Inc. | P Buy | 2023-11-13 | 2023-11-15 | 2,376 | $20.54 | $48.8K | 2,376 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 6,300 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 10,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 99 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 520 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 2,137 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 169 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 5,620 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 6,116 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 169 | $73.68 | $12.5K | 169 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-06-07 | 2023-06-09 | 2,137 | — | $0 | 2,137 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 1,682 | $93.61 | $157.5K | 6,116 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-06-07 | 2023-06-09 | 133 | $93.61 | $12.5K | 4,434 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2023-06-01 | 2023-06-05 | 12,535 | — | $0 | 12,535 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2023-04-28 | 2023-04-28 | 96,000 | — | $0 | 96,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2022-06-10 | 2022-06-14 | 9,367 | — | $0 | 9,367 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 520 | $24.02 | $12.5K | 520 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-06-08 | 2022-06-09 | 5,620 | — | $0 | 5,620 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 17,550 | — | $0 | 17,550 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 3,883 | $34.76 | $135.0K | 4,301 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-06-08 | 2022-06-09 | 359 | $34.76 | $12.5K | 418 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2022-04-28 | 2022-04-29 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 99 | $16.14 | $1.6K | 99 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 59 | $27.32 | $1.6K | 59 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-09-30 | 2021-10-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VRNA Verona Pharma plc | A Award deriv | 2021-08-09 | 2021-08-10 | 64,000 | — | $0 | 64,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2021-06-16 | 2022-04-29 | 9,996 | — | $0 | 9,996 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-06-10 | 2021-06-14 | 5,000 | — | $0 | 5,000 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-05-04 | 2021-05-05 | 12,024 | $0.84 | $10.1K | 111,064 | SEC↗ |
| VRNA Verona Pharma plc | S Sale | 2021-02-01 | 2021-02-03 | 13,688 | $0.99 | $13.6K | 123,088 | SEC↗ |
| MORF Morphic Holding, Inc. | A Award deriv | 2020-12-01 | 2020-12-03 | 24,000 | — | $0 | 24,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-10-01 | 2020-10-02 | 7,000 | — | $0 | 7,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2020-08-03 | 2020-08-04 | 6,300 | — | $0 | 6,300 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2020-08-03 | 2020-08-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 9,367 | — | $0 | 9,367 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-06-26 | 2019-06-28 | 14,000 | — | $0 | 14,000 | SEC↗ |